Urogen Pharma Ltd (URGN)

Cash & Short-Term Investments

$107.98M

Quarterly · Period ending: · USD

URGN logo

URGN Cash & Short-Term Investments

Latest reported$107.98M
URGN Quarterly Cash & Short-Term Investments ($3.87M → $107.98M)
High-resolution chart · PNG

URGN cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
107,975,000
141,601,000
120,456,000
127,033,000
156,954,000
195,890,000
236,685,000
249,575,000
241,078,000
164,868,000
137,789,000
147,419,000
47,301,000
65,054,000
99,964,000
95,911,000
111,738,000
136,444,000
89,139,000
106,209,000
121,032,000
75,909,000
102,018,000
119,623,000
125,123,000
119,091,000
147,077,000
158,193,000
189,163,000
246,692,000
101,318,000
109,483,000
119,109,000
127,460,000
73,000,000
79,171,000
77,093,000
21,362,000
21,362,000
8,206,000
15,070,000
15,070,000
17,975,000
3,870,000
3,870,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.